This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dong, Y. Articles by Yonekura, Y. Search for Related Content PubMed PubMed Citation Articles by Dong, Y. Articles by Yonekura, Y. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Nuclear Scans

(Stroke. 1997;28:1776-1782.)
© 1997 American Heart Association, Inc.

Articles

Assessment of Benzodiazepine Receptors Using Iodine-123–Labeled Iomazenil Single-Photon Emission Computed Tomography in Patients With Ischemic Cerebrovascular Disease

A Comparison With PET Study

Yun Dong, MD; Hidenao Fukuyama, MD; Hidehiko Nabatame, MD; Hiroshi Yamauchi, MD; Hiroshi Shibasaki, MD; Yoshiharu Yonekura, MD

From the Departments of Brain Pathophysiology (Y.D., H.F., H.S.) and Neurology (H.Y.), Faculty of Medicine, Kyoto University; Department of Neurology, Shiga Medical Center for Adult Disease (H.N.), Moriyama, Shiga; and Biomedical Center, Fukui Medical School (Y.Y.), Fukui, Japan.

Background and Purpose [¹²³I]Iomazenil (IMZ) is a tracer used for single-photon emission computed tomography (SPECT) that has the characteristics of selectively binding to central benzodiazepine receptors (BZR) in the neuron membrane. To determine whether IMZ SPECT provides new information on assessing neuronal damage after ischemic insult to the brain, we compared IMZ SPECT images with the cerebral blood flow (CBF), cerebral metabolic rate of oxygen (CMRO₂), and cerebral metabolic rate of glucose (CMRGlc) studied by positron emission tomography in the chronic stage of ischemic stroke.

Methods Five patients (male; mean age, 63.2±6.0 years) with ischemic cerebrovascular disease and 6 age- and sex-matched normal control subjects were studied. IMZ images obtained 180 minutes after injection were analyzed for BZR binding, and these images were compared with the CBF, CMRO₂, and CMRGlc obtained by positron emission tomography in the same perfusion areas both visually and quantitatively.

Results In the visual analysis of data obtained from 4 patients with subcortical infarction, decreased IMZ accumulation was observed locally in the overlying normal-appearing cortices of the affected hemisphere, where extensive hypoperfusion and hypometabolism were seen on the images of CBF, CMRO₂, and CMRGlc. The regional relative IMZ uptake (regional to cerebellar ratio) for all 5 patients was significantly correlated with the corresponding regional CMRO₂ values (r=.45, P<.05). However, no significant correlation was found of the IMZ uptake with either the regional CBF or the regional CMRGlc.

Conclusions The use of IMZ SPECT provides new information on the neuronal alteration induced by chronic ischemic cerebrovascular disease.

Key Words: cerebral blood flow • cerebral oxygen metabolism • receptors, benzodiazepine • tomography, emission

This article has been cited by other articles:

				J. V. Guadagno, P. S. Jones, F. I. Aigbirhio, D. Wang, T. D. Fryer, D. J. Day, N. Antoun, I. Nimmo-Smith, E. A. Warburton, and J. C. Baron Selective neuronal loss in rescued penumbra relates to initial hypoperfusion Brain, October 1, 2008; 131(10): 2666 - 2678. [Abstract] [Full Text] [PDF]

				C. Giffard, B. Landeau, N. Kerrouche, A. R. Young, L. Barre, and J.-C. Baron Decreased Chronic-Stage Cortical 11C-Flumazenil Binding After Focal Ischemia-Reperfusion in Baboons: A Marker of Selective Neuronal Loss? Stroke, March 1, 2008; 39(3): 991 - 999. [Abstract] [Full Text] [PDF]

				D. Saur, R. Buchert, R. Knab, C. Weiller, and J. Rother Iomazenil-Single-Photon Emission Computed Tomography Reveals Selective Neuronal Loss in Magnetic Resonance-Defined Mismatch Areas Stroke, November 1, 2006; 37(11): 2713 - 2719. [Abstract] [Full Text] [PDF]

				H. Yamauchi, T. Kudoh, Y. Kishibe, J. Iwasaki, and S. Kagawa Selective Neuronal Damage and Borderzone Infarction in Carotid Artery Occlusive Disease: A 11C-Flumazenil PET Study J. Nucl. Med., December 1, 2005; 46(12): 1973 - 1979. [Abstract] [Full Text] [PDF]

				H. Yamauchi, H. Okazawa, K. Sugimoto, Y. Kishibe, and M. Takahashi The Effect of Deafferentation on Cerebral Blood Flow Response to Acetazolamide AJNR Am. J. Neuroradiol., January 1, 2004; 25(1): 92 - 96. [Abstract] [Full Text] [PDF]

				J. Fiehler, M. Foth, T. Kucinski, R. Knab, M. von Bezold, C. Weiller, H. Zeumer, and J. Rother Severe ADC Decreases Do Not Predict Irreversible Tissue Damage In Humans Stroke, January 1, 2002; 33(1): 79 - 86. [Abstract] [Full Text] [PDF]

				E. E. Camargo Brain SPECT in Neurology and Psychiatry J. Nucl. Med., April 1, 2001; 42(4): 611 - 623. [Abstract] [Full Text]

				H Yamauchi, H Fukuyama, Y Dong, H Nabatame, Y Nagahama, S Nishizawa, J Konishi, and H Shio Atrophy of the corpus callosum associated with a decrease in cortical benzodiazepine receptor in large cerebral arterial occlusive diseases J. Neurol. Neurosurg. Psychiatry, March 1, 2000; 68(3): 317 - 322. [Abstract] [Full Text] [PDF]